Mineralys Therapeutics, Inc. (MLYS)
26.62
-0.55
(-2.02%)
USD |
NASDAQ |
Apr 10, 16:00
26.62
0.00 (0.00%)
After-Hours: 20:00
Mineralys Therapeutics Total Liabilities (Quarterly) : 15.11M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Syndax Pharmaceuticals, Inc. | 465.08M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Immunic, Inc. | 30.72M |
| Cogent Biosciences, Inc. | 301.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.81M |
| Shareholders Equity (Quarterly) | 646.69M |
| Current Ratio | 43.76 |